Background: Previous studies have suggested that the balance between receptor activator
of nuclear factor-κB ligand (RANKL) and its decoy-receptor osteoprotegerin (OPG) in local …

OBJECTIVE: To evaluate serum levels of osteoprotegerin (OPG) and receptor activator of
nuclear factor kB-ligand (RANK-L) in patients with juvenile idiopathic arthritis (JIA); to …

Objective: Currently published data regarding the potential role of osteoprotegerin (OPG),
osteocalcin (OCN) and osteopontin (OPN) for the discrimination between rheumatoid …

Objective: To evaluate the importance of receptor activator of nuclear factor κB
(RANK)/receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) …

Background The aim of this study was to clarify the significance of subchondral bone in the
pathology of osteoarthritis (OA) by investigating the expression of inflammatory cyto-kines …

Objective Dickkopf-1 (Dkk-1) regulates bone remodeling in animal models of inflammatory
arthritis, but its role in patients with rheumatoid arthritis (RA) remains unclear. Methods …

Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with
rheumatoid arthritis in response to disease‐modifying antirheumatic drug treatment and …

Aims Osteoprotegerin and the receptor activator of the nuclear factor-κB ligand (RANKL) are
decisive factors for maintaining the balance between bone formation and bone resorption …

Objective The receptor activator of nuclear factor κB (RANK) is a member of the tumor
necrosis factor receptor family. It is activated by the secreted or cell surface–bound RANK …

Objective Although the osteoprotegerin (OPG)/RANK/RANKL system is the main modulator
of bone remodeling, it remains unclear whether it is regulated in cartilage during …